|
OXSR1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.39324140902409E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.06319997250637E-09 |
| Normal-vs-Stage2 |
1.84650000001341E-06 |
| Normal-vs-Stage3 |
1.59089963425174E-10 |
| Normal-vs-Stage4 |
2.51360043890259E-10 |
| Stage1-vs-Stage2 |
9.898800E-01 |
| Stage1-vs-Stage3 |
1.010240E-01 |
| Stage1-vs-Stage4 |
4.507700E-02 |
| Stage2-vs-Stage3 |
2.577000E-01 |
| Stage2-vs-Stage4 |
1.375430E-01 |
| Stage3-vs-Stage4 |
6.699000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.11339867617744E-11 |
| Normal-vs-AfricanAmerican |
6.838400E-04 |
| Normal-vs-Asian |
3.1399000000043E-07 |
| Caucasian-vs-AfricanAmerican |
4.834800E-01 |
| Caucasian-vs-Asian |
8.426800E-01 |
| AfricanAmerican-vs-Asian |
4.469200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.47929479566278E-11 |
| Normal-vs-Female |
6.09019501496277E-11 |
| Male-vs-Female |
3.044600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.91330000415869E-08 |
| Normal-vs-Age(41-60Yrs) |
7.72230057677348E-11 |
| Normal-vs-Age(61-80Yrs) |
3.66009444974225E-11 |
| Normal-vs-Age(81-100Yrs) |
2.122800E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.078400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.120400E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.734600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.286000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.336000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.224800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.492500E-02 |
| Classical-VS-Follicular |
8.943600E-03 |
| Classical-VS-Other |
7.959200E-01 |
| Classical-VS-Normal |
1.83630000094581E-09 |
| Tall-VS-Follicular |
9.928800E-01 |
| Tall-VS-Other |
5.734600E-01 |
| Tall-VS-Normal |
4.53259999977362E-07 |
| Follicular-VS-Other |
5.841800E-01 |
| Follicular-VS-Normal |
7.82919951092254E-10 |
| Other-VS-Normal |
2.085700E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.86182230427812E-12 |
| Normal-vs-N1 |
2.41550002222368E-09 |
| N0-vs-N1 |
2.652200E-01 |
|
|
